Results 241 to 250 of about 2,785,155 (317)
Lens Extraction for Primary Angle Closure Glaucoma : a rapid systematic review [PDF]
, 2007 Burr, Jennifer Margaret +1 more
core
Congenital aniridia: European COST action ANIRIDIA‐NET guidelines for diagnosis, management and care
Acta Ophthalmologica, Volume 104, Issue 3, Page 267-279, May 2026.Abstract Congenital aniridia is a rare ocular disorder affecting the majority of eye structures and can be associated with systemic manifestations. The main visible phenotypic characteristic is the partial or complete absence of the iris; however, foveal hypoplasia is a more frequent and reliable clinical sign. Other ocular comorbidities are associated
Davide Romano +26 more
wiley +1 more source
Acta Ophthalmologica, Volume 104, Issue 3, Page e292-e299, May 2026.Abstract Purpose This study evaluates whether mesopic microperimetry (MMP) provides a more robust measure of retinal function compared to visual acuity (VA) in age‐related macular degeneration (AMD) clinical trials, with a focus on optimal analysis strategies. Method Fellow‐eyes of unilateral neovascular AMD were prospectively studied.
Francesco Cinque +9 more
wiley +1 more source
Exploring the histopathological signature of repeat‐mediated Fuchs endothelial corneal dystrophy
Acta Ophthalmologica, Volume 104, Issue 3, Page 333-341, May 2026.Abstract Purpose To determine the histological differences between Fuchs endothelial corneal dystrophy (FECD) cases with and without the most common genetic risk factor, expansion of a CTG repeat (CTG18.1) within the TCF4 gene. Methods Formalin‐fixed paraffin‐embedded corneal tissues were compared retrospectively, and CTG18.1 status was determined from
Anne‐Marie S. Kladny +5 more
wiley +1 more source
Advances in the genetics of refractive errors: Contributions from the CREAM consortium
Acta Ophthalmologica, Volume 104, Issue 3, Page e222-e231, May 2026.Abstract The Consortium for Refractive Error and Myopia (CREAM) was established in 2011, bringing together an international team of researchers studying more than 30 cohorts. Since its establishment, CREAM has played a pivotal role in research investigating the genetics of myopia and other refractive errors, serving as a key driver of progress in the ...
Sze Wai Rosa Li +11 more
wiley +1 more source
Acta Ophthalmologica, Volume 104, Issue 3, Page e232-e238, May 2026.Abstract Purpose To determine the long‐term blindness rate and related prognostic factors in eyes with open‐angle glaucoma after trabeculectomy using adjunctive mitomycin C (MMC). Methods The retrospective cohort study included 714 eyes from 714 patients with open angle glaucoma who underwent trabeculectomy using MMC.
Masato Matsuo +5 more
wiley +1 more source
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source
A common variant in MIR182 is associated with primary open-angle glaucoma in the NEIGHBORHOOD consortium [PDF]
, 2016 Gordon, Mae O., Kass, Michael A.
core +1 more source
Practical Recommendations for Anticoagulation in Patients With Atrial Fibrillation
European Journal of Clinical Investigation, Volume 56, Issue 5, May 2026.Oral anticoagulation (OAC) reduces stroke risk by at least two thirds and mortality by one fourth. The threshold for net clinical benefit of OAC is met when stroke risk exceeds 1%–2% per year. Direct oral anticoagulants (DOACs) are preferred to vitamin K antagonists (VKAs) in most patients, including in the elderly and chronic kidney disease ...
Nicolas Johner, Baris Gencer
wiley +1 more source
International Wound Journal, Volume 23, Issue 5, May 2026.ABSTRACT Diabetic foot ulcers (DFUs) are serious complications of diabetes, characterised by impaired healing driven in part by pro‐inflammatory macrophage activity. ON101, a topical macrophage‐modulating cream, promotes M1‐to‐M2 transition and improves wound healing.
Chia‐Ding Shih +5 more
wiley +1 more source